<DOC>
	<DOCNO>NCT02118272</DOCNO>
	<brief_summary>The aim study assess clinical , radiographic patient-reported outcome measure ( PROMs ) total knee replacement Physica KR , define survivorship implant identify possible risk factor may lead failure .</brief_summary>
	<brief_title>Clinical Study Evaluating Outcomes New Knee System With Physiological Rollback Mechanism</brief_title>
	<detailed_description />
	<criteria>1 . Male female 2 . Age 2280 year 3 . Any race 4 . Ambulatory patient 5 . Patients medical condition 5 year life expectancy 6 . Patients require knee prosthesis , suitable use Physica KR 7 . Patients painful primary knee osteoarthritis 8 . Patients painful secondary knee osteoarthritis 9 . Patients suffer inflammatory arthritis ( e.g . rheumatoid arthritis ) 10 . Patients undamaged functional collateral posterior cruciate ligament 11 . Patients flexion great equal 90째 affected side 12 . Patients fixed flexion contracture le 10째 13 . Patients understand condition study willing able comply prescribe rehabilitation perform schedule followup visit 14 . Patients sign Ethics Committee approve studyspecific Informed Consent Form prior surgery 1 . Obese patient BMI 35 kg/m2 ( severe obesity ) 2 . Previous partial knee replacement ( unilateral , bicompartimental patellofemoral joint replacement ) , patellectomy , high tibial osteotomy femoral osteotomy affect knee 3 . Primary Total Knee Replacement ( TKR ) affect knee 4 . Varus Valgus deformity great 20째 5 . Patients fixed flexion contracture great 10째 6 . Previous knee replacement contralateral side within last year whose outcome achieve KSS &lt; 70 point 7 . Patients symptomatic OA hip , spine , ankle , interfere evaluation target knee 8 . Patients active suspected infection ( affected knee systemic ) 9 . Muscular insufficiency absence muscoligamentous support structure require adequate soft tissue balance 10 . Patients know suspicious metal hypersensitivity 11 . Recurrent medical history severe allergic immunemediated reaction 12 . Vascular insufficiency lower limb severe enough interfere study evaluation 13 . Current treatment treatment within previous 2 year screen visit malignant lifethreatening nonmalignant disorder 14 . Any clinically significant pathology base clinical history Investigator feel may affect study evaluation 15 . Any intercurrent chronic disease condition may interfere completion 5year followup , liver disease , severe coronary disease , alcohol drug abuse , disorder mental state , clinically significant condition 16 . Patients significant neurological musculoskeletal disorder disease may adversely affect gait compromise functional recovery evaluation 17 . Patients neuromuscular neurosensory deficit would limit ability assess performance device 18 . Patients systemic metabolic disorder lead progressive bone deterioration 19 . Patients medical condition le 5 year life expectancy 20 . Previous organ transplant surgery 21 . Any psychiatric illness would prevent comprehension detail nature study 22 . Participation experimental drug/device study within 6 month prior screen visit 23 . Female patient pregnant , nursing , plan pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>